Showing results (1301-1310 of 2,457) with videos related to
Sort By:
Pageof 246
Anticancer Research|September 27, 2015
Targeting Topoisomerase II Activity in NSCLC with 9-Aminoacridine DerivativesDavid M Ferguson, Blake A Jacobson, Joe Jay-Dixon, et al.Pediatrics|June 18, 2016
Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose CyclophosphamideLisa A Jacobson, Shruti Rane, Lisa J McReynolds, et al.Immunity|October 1, 1995
Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient miceB A Jacobson, D J Panka, K A Nguyen, et al.AJR. American Journal of Roentgenology|January 22, 2009
Sonography of the normal ankle: a target approach using skeletal reference pointsMichel De Maeseneer, Stefaan Marcelis, Tjeerd Jager, et al.Bioconjugate Chemistry|March 1, 1991
Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptorsD L Boring, X D Ji, J Zimmet, et al.ACS Pharmacology & Translational Science|April 16, 2021
Adenosine Kinase Expression Determines DNA Methylation in Cancer Cell LinesAmir E Wahba, Denise Fedele, Hoda Gebril, et al.Annals of the New York Academy of Sciences|November 14, 2019
Precision medicine, agriculture, and genome editing: science and ethicsCarlos G Moscoso, Kelly R Potz, Shaoyuan Tan, et al.Journal of Medicinal Chemistry|November 11, 1994
Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivativesH O Kim, X D Ji, N Melman, et al.Brain, Behavior, and Immunity|September 16, 2014
Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathyKali Janes, Carrie Wahlman, Joshua W Little, et al.Nature|April 4, 2014
Highly siderophile elements in Earth's mantle as a clock for the Moon-forming impactSeth A Jacobson, Alessandro Morbidelli, Sean N Raymond, et al.Pageof 246